Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study

著者: Peter A. Campochiaro, Robert L. Avery, David M. Brown, Jeffrey S. Heier, Allen C. Ho, Stephen Huddleston, Glenn J. Jaffe, Arshad M. Khanani, Stephen Pakola, Dante J. Pieramici, Charles C. Wykoff, Sherri Van Everen - The Lancet 2024 被引用: 119